3,6,9,12-TETRAOXATETRADECANOIC ACID, 14-(((5.ALPHA.,6.ALPHA.)-4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPEN-1-YL)MORPHINAN-6-YL)OXY)-
UNII V475ZW9MQR
Substance Identification & Data
This profile provides standardized clinical and technical data for 3,6,9,12-tetraoxatetradecanoic Acid, 14-(((5.alpha.,6.alpha.)-4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-yl)oxy)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V475ZW9MQR.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2194602-17-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H41NO10 WRNQPYNOCLPVAH-IYRMEPLZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3,6,9,12-tetraoxatetradecanoic Acid, 14-(((5.alpha.,6.alpha.)-4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-yl)oxy)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.